Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.
James P CurtainKieran F DochertyPardeep S JhundMark Colquhoun PetrieSilvio E InzucchiLars Valeur KøberMikhail N KosiborodFelipe A MartinezPiotr PonikowskiMarc S SabatineOlof F BengtssonAnna Maria LangkildeMikaela SjöstrandScott D SolomonJohn Joseph Valentine McMurrayPublished in: European heart journal (2021)
ClinicalTrials.gov unique identifier: NCT03036124 (DAPA-HF).